Condition
Carcinoma, Non-Small-Cell Lung|Carcinoma, Small Cell Lung|Mesothelioma
Estimated Enrollment: 50
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention
Study ID Numbers: LTC-510-100108-Bahce|CCMO: NL19614.091.07|EudraCT: 2007-002787-95
Study First Received: March 11, 2008
Last Updated: August 8, 2011
Estimated Primary Completion Date: December 2011
Primary Outcome Measures:
The occurrence of peripheral neuropathy: with the peripheral neuropathy score (PNP-score) and the electrophysiological measurements. If no EMG is available, then audiometric measurements will be taken into account.|haematological abnormalities|creatinine clearance.|liver chemistry abnormalities|Karnofski Performance Score|Quality of life
Sponsors and Collaborators:
Rijnstate Hospital
Website Link: https://ClinicalTrials.gov/show/NCT00637624
